首页> 外文期刊>Medycyna Pracy >Occupational contact allergy to omeprazole and ranitidine
【24h】

Occupational contact allergy to omeprazole and ranitidine

机译:对奥美拉唑和雷尼替丁的职业接触过敏

获取原文
           

摘要

Omeprazole is a proton pump inhibition and ranitidine is an H2 histamine receptor antagonist widely used in the treatment ofgastroesophageal reflex disease, peptic ulcer disease, Zollinger-Ellison syndrome and as a protector of the gastric mucosae. We reporta case of occupational contact allergy to omeprazole and ranitidine. A 48-year-old man, with no pre-existing history of atopyor lifestyle factors. He neither had any medical history of consumption of drugs such as ranitidine and omeprazole. He workedfor 19 months in the pharmaceutical company that manufactured ranitidine base. He presented rash in the face and eczema onthe dorsum of the hands with itching. The study by prick tests with ranitidine gave negative response. Patch testing with ranitidinebase and ranitidine hydrochloride gave positive response. A month later, when the patient was asymptomatic he returned to thepharmaceutical company, being switched from this previous job to the reactor manufacturing omeprazole. A few days after that,he presented erythematous eruptions involving face and neck with itching. Prick tests, path tests and in vitro laboratories studieswith omeprazole gave positives. In this case the patient presented hypersensitivity type I at omeprazole and hypersensitivitytype IV at omeprazole and ranitidine. Our aportation indicates the importance of careful analysis of the occupational exposurehistories of patients with the suspected type I or type IV hypersensitivity to allergens, to determine whether work exposure is thecause. Med Pr 2017;68(3):433–435
机译:奥美拉唑是一种质子泵抑制剂,雷尼替丁是一种H2组胺受体拮抗剂,广泛用于治疗胃食管反射疾病,消化性溃疡疾病,佐林格-埃里森综合征以及作为胃粘膜的保护剂。我们报告了对奥美拉唑和雷尼替丁的职业接触过敏的病例。一名48岁的男性,无特应性生活方式因素的病史。他也没有任何服用雷尼替丁和奥美拉唑等药物的病史。他在制造雷尼替丁碱的制药公司工作了19个月。他出现瘙痒,脸上出现皮疹,手背出现湿疹。雷尼替丁通过点刺试验的研究结果为阴性。用雷尼替丁碱和雷尼替丁盐酸盐进行的贴剂测试显示阳性反应。一个月后,当患者无症状时,他回到了制药公司,从之前的工作转到了制造奥美拉唑的反应器。几天后,他出现了瘙痒的面部和颈部红斑疹。奥美拉唑的点刺试验,路径试验和体外实验室研究均呈阳性。在这种情况下,患者在奥美拉唑时出现I型超敏反应,在奥美拉唑和雷尼替丁时出现IV型超敏反应。我们的驱离表明,仔细分析怀疑对过敏原具有I型或IV型过敏症的患者的职业暴露史,以确定是否应引起工作暴露。医学杂志2017; 68(3):433–435

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号